Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy
Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy have?
Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy has 396 citations in the OpenAlex counts ScholarIQ stores.
When was Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy published?
Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy has 2020 year in the ScholarIQ index.
What is the open-access status of Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy?
Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy has closed oa status in the ScholarIQ index.
What is the DOI of Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy?
The DOI for Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy is on the source record.
What is the PMID of Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy?
The PMID for Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy is on the source record.
What is the OpenAlex record for Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy?
The OpenAlex for Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy is on the source record.